Effectiveness of Topiramate in Treating Cocaine Dependent Individuals - 1
NCT00249691 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 180
Last updated 2012-03-08
Summary
Although a great amount of research has been conducted to resolve cocaine dependence, an effective treatment has yet to be discovered. Topiramate is a drug that was found to be useful in treating alcohol dependence. The purpose of this study is to determine the effectiveness of topiramate in treating cocaine dependent individuals.
Conditions
- Cocaine-Related Disorders
Interventions
- DRUG
-
Topiramate + Cognitive Behavioral Therapy
Topiramate up to 300 mg per day
- DRUG
-
Placebo + Cognitive Behavioral Therapy
Placebo twice a day
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
Bankole Johnson
lead OTHER
Principal Investigators
-
Bankole Johnson · University of Virginia
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-10-31
- Primary Completion
- 2011-10-31
- Completion
- 2012-10-31
Countries
- United States
Study Locations
More Related Trials
-
Topiramate-Phentermine Combinations for Cocaine Dependence
NCT02239913 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Memantine in Treating Cocaine-Dependent Individuals - 2
NCT00134901 ·Status: COMPLETED ·Phase: PHASE2
-
Medications for Stopping Cocaine Dependence and Preventing Relapse
NCT00218023 ·Status: COMPLETED ·Phase: PHASE2
-
Carbamazepine Treatment of Cocaine Dependence - 1
NCT00000242 ·Status: COMPLETED ·Phase: PHASE2
-
Modafinil for the Treatment of Cocaine Dependence - 1
NCT00100100 ·Status: COMPLETED ·Phase: PHASE2
-
Modafinil Treatment for Cocaine-Dependent Individuals
NCT00129285 ·Status: COMPLETED ·Phase: PHASE2
-
A Placebo-Controlled Study of Mixed Amphetamine Salts and Topiramate for the Treatment of Cocaine Dependence
NCT00421603 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Cabergoline for the Treatment of Cocaine Dependence - 1
NCT00033111 ·Status: COMPLETED ·Phase: PHASE2
-
Piracetam for Treatment of Cocaine Addiction - 3
NCT00000198 ·Status: COMPLETED ·Phase: PHASE1
-
Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
NCT00000276 ·Status: TERMINATED ·Phase: PHASE1
-
A Placebo-Controlled Double-Blind Combined Treatment of Modafinil and CBT for Cocaine Dependence
NCT00344565 ·Status: COMPLETED ·Phase: PHASE2
-
Modafinil Combined With Cognitive Behavior Therapy to Treat Cocaine Addiction - 1
NCT00218387 ·Status: COMPLETED ·Phase: PHASE2
-
Carbamazepine Treatment for Cocaine Dependence - 5
NCT00000191 ·Status: COMPLETED ·Phase: PHASE2
-
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
NCT01030692 ·Status: COMPLETED ·Phase: PHASE1
-
Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals
NCT00217997 ·Status: COMPLETED
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1
NCT00040066 ·Status: UNKNOWN ·Phase: PHASE1
-
Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence
NCT01811940 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Cognitive Remediation for Cocaine Dependence
NCT01393457 ·Status: COMPLETED ·Phase: PHASE2
-
Piracetam for Treatment of Cocaine Addiction, Phase II - 4
NCT00000199 ·Status: WITHDRAWN ·Phase: PHASE1
-
Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence
NCT00218075 ·Status: COMPLETED ·Phase: PHASE2
-
Modafinil, Sleep, and Cognition in Cocaine Dependence
NCT00582491 ·Status: COMPLETED ·Phase: NA
-
Cocaine and Zolmitriptan
NCT05019430 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Tryptophan and Behavior Therapy for Cocaine Abuse - 1
NCT00000324 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of GABA Agonists in Reducing the Reinforcing Effects of Cocaine
NCT00218166 ·Status: COMPLETED ·Phase: PHASE2
-
Striatal Effective Connectivity to Predict Treatment Response in Cocaine Misuse
NCT02080819 ·Status: COMPLETED ·Phase: PHASE2